Cargando…

The Prognostic Model Based on Tumor Cell Evolution Trajectory Reveals a Different Risk Group of Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related death worldwide, and heterogeneity of HCC is the major barrier in improving patient outcome. To stratify HCC patients with different degrees of malignancy and provide precise treatment strategies, we reconstructed the tumo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Haoren, Yu, Shizhe, Cai, Qiang, Ma, Duo, Yang, Lingpeng, Zhao, Jian, Jiang, Long, Zhang, Xinyi, Yu, Zhiyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511531/ https://www.ncbi.nlm.nih.gov/pubmed/34660596 http://dx.doi.org/10.3389/fcell.2021.737723

Ejemplares similares

Significance of Liver Zonation in Hepatocellular Carcinoma
por: Yu, Shizhe, et al.
Publicado: (2022)

Spatial transcriptome profiling of normal human liver
por: Yu, Shizhe, et al.
Publicado: (2022)

Genomic Instability of Mutation-Derived Gene Prognostic Signatures for Hepatocellular Carcinoma
por: Song, Ze-Bing, et al.
Publicado: (2021)

The Landscape of Using Glycosyltransferase Gene Signatures for Overall Survival Prediction in Hepatocellular Carcinoma
por: Cai, Qiang, et al.
Publicado: (2022)

Tenogenic Induction From Induced Pluripotent Stem Cells Unveils the Trajectory Towards Tenocyte Differentiation
por: Yoshimoto, Yuki, et al.
Publicado: (2022)

Identification of Subtypes and a Prognostic Gene Signature in Colon Cancer Using Cell Differentiation Trajectories
por: Xiang, Renshen, et al.
Publicado: (2021)

Development and validation of a copper-related gene prognostic signature in hepatocellular carcinoma
por: Shi, Haoting, et al.
Publicado: (2023)

RPL19 Is a Prognostic Biomarker and Promotes Tumor Progression in Hepatocellular Carcinoma
por: Rao, Benchen, et al.
Publicado: (2021)

Comprehensive Transcriptomic Analysis Reveals Prognostic Value of an EMT-Related Gene Signature in Colorectal Cancer
por: Mo, Shaobo, et al.
Publicado: (2021)

Systematic Characterization of Novel Immune Gene Signatures Predicts Prognostic Factors in Hepatocellular Carcinoma
por: Xu, Dafeng, et al.
Publicado: (2021)

A novel prognostic prediction model of cuprotosis-related genes signature in hepatocellular carcinoma
por: Shao, Ruo-Nan, et al.
Publicado: (2023)

Identification of lipid metabolism-associated genes as prognostic biomarkers based on the immune microenvironment in hepatocellular carcinoma
por: Gu, Xiangqian, et al.
Publicado: (2022)

Molecular typing and prognostic risk models for ovarian cancer: a study based on cell differentiation trajectory
por: Chen, Tingfeng, et al.
Publicado: (2023)

The Role of Ferroptosis in the Treatment and Drug Resistance of Hepatocellular Carcinoma
por: Zhao, Siqi, et al.
Publicado: (2022)

Comprehensive analysis to identify the neurotransmitter receptor-related genes as prognostic and therapeutic biomarkers in hepatocellular carcinoma
por: Wang, Xiaoqiang, et al.
Publicado: (2022)

A Novel Pyroptosis-related Prognostic Model for Hepatocellular Carcinoma
por: Wu, Qianqian, et al.
Publicado: (2021)

Systematic Construction and Validation of a Prognostic Model for Hepatocellular Carcinoma Based on Immune-Related Genes
por: Yu, Jiahao, et al.
Publicado: (2021)

Identification of Immune-Related Genes for Establishment of Prognostic Index in Hepatocellular Carcinoma
por: Li, Yinfang, et al.
Publicado: (2021)

Development and Validation of a Novel Mitochondrion and Ferroptosis-Related Long Non-Coding RNA Prognostic Signature in Hepatocellular Carcinoma
por: Xia, Wuzheng, et al.
Publicado: (2022)

Corrigendum: Detecting key functional components group and speculating the potential mechanism of Xiao-Xu-Ming decoction in treating stroke
por: Chen, Yu-peng, et al.
Publicado: (2023)

Development and Validation of a Combined Ferroptosis and Immune Prognostic Classifier for Hepatocellular Carcinoma
por: Liu, Yang, et al.
Publicado: (2020)

Downregulated Ferroptosis-Related Gene STEAP3 as a Novel Diagnostic and Prognostic Target for Hepatocellular Carcinoma and Its Roles in Immune Regulation
por: Yan, Yuanliang, et al.
Publicado: (2021)

Immunological Value of Prognostic Signature Based on Cancer Stem Cell Characteristics in Hepatocellular Carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

Diagnostic, Therapeutic, and Prognostic Value of the m(6)A Writer Complex in Hepatocellular Carcinoma
por: Gu, Zongting, et al.
Publicado: (2022)

Identification of the Expression Patterns and Potential Prognostic Role of 5-Methylcytosine Regulators in Hepatocellular Carcinoma
por: Liu, Yong, et al.
Publicado: (2022)

Bioinformatics Study Revealed Significance of Exosome Transcriptome in Hepatocellular Carcinoma Diagnosis
por: Wu, Zeng-Hong, et al.
Publicado: (2022)

Pan-cancer and single-cell analysis reveal the prognostic value and immune response of NQO1
por: Shen, Liping, et al.
Publicado: (2023)

Network Pharmacology and Experimental Validation Reveal the Effects of Chidamide Combined With Aspirin on Acute Myeloid Leukemia-Myelodysplastic Syndrome Cells Through PI3K/AKT Pathway
por: Liang, Simin, et al.
Publicado: (2021)

Integratively Genomic Analysis Reveals the Prognostic and Immunological Characteristics of Pyroptosis and Ferroptosis in Pancreatic Cancer for Precision Immunotherapy
por: Yu, Ting, et al.
Publicado: (2022)

A Novel Ferroptosis-Related Prognostic Signature Reveals Macrophage Infiltration and EMT Status in Bladder Cancer
por: Yan, Yilin, et al.
Publicado: (2021)

Landscape of Prognostic m6A RNA Methylation Regulators in Hepatocellular Carcinoma to Aid Immunotherapy
por: Xu, Qianhui, et al.
Publicado: (2021)

High Visceral Adipose Tissue Density Correlates With Unfavorable Outcomes in Patients With Intermediate-Stage Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
por: Li, Qiang, et al.
Publicado: (2021)

Comprehensive Analyses of MELK-Associated ceRNA Networks Reveal a Potential Biomarker for Predicting Poor Prognosis and Immunotherapy Efficacy in Hepatocellular Carcinoma
por: Liu, Yu, et al.
Publicado: (2022)

Construction and Validation of Two Hepatocellular Carcinoma-Progression Prognostic Scores Based on Gene Set Variation Analysis
por: He, Qifan, et al.
Publicado: (2022)

Prenatal Developmental Trajectories of Fluctuating Asymmetry in Bat Humeri
por: López-Aguirre, Camilo, et al.
Publicado: (2021)

Ferroptosis Characterization in Lung Adenocarcinomas Reveals Prognostic Signature With Immunotherapeutic Implication
por: Sun, Sijin, et al.
Publicado: (2021)

Novel gene signature reveals prognostic model in acute lymphoblastic leukemia
por: Chen, Panpan, et al.
Publicado: (2022)

An Analysis Regarding the Prognostic Significance of MAVS and Its Underlying Biological Mechanism in Ovarian Cancer
por: Chen, Lifeng, et al.
Publicado: (2021)

Genetic Mechanism for the Cyclostome Cerebellar Neurons Reveals Early Evolution of the Vertebrate Cerebellum
por: Sugahara, Fumiaki, et al.
Publicado: (2021)

Combined DNA Methylation and Transcriptomic Assessments to Determine a Prognostic Model for PD-1-Negative Hepatocellular Carcinoma
por: Zhu, Lixu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mn7b62vfnoee8t0ks3r08bq7r4